Protalix BioTherapeutics (PLX) Free Cash Flow Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 60.84% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 88.70% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -15.72% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 66.37% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 3.98% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 137.65% |
| 10 | Protalix BioTherapeutics | 164.49 Mn | 153.70 Mn | 29.62 Mn | 496.34% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 496.34% |
| Dec 31, 2025 | -36.96% |
| Sep 30, 2025 | -225.56% |
| Jun 30, 2025 | -76.92% |
| Mar 31, 2025 | -252.79% |
| Dec 31, 2024 | 42.05% |
| Sep 30, 2024 | 150.37% |
| Jun 30, 2024 | -165.70% |
| Mar 31, 2024 | 210.60% |
| Dec 31, 2023 | 226.87% |
| Sep 30, 2023 | 28.29% |
| Jun 30, 2023 | 166.16% |
| Mar 31, 2023 | 46.42% |
| Dec 31, 2022 | 53.95% |
| Sep 30, 2022 | -319.42% |
| Jun 30, 2022 | -215.61% |
| Mar 31, 2022 | 40.72% |
| Dec 31, 2021 | 26.07% |
| Sep 30, 2021 | 39.99% |
| Jun 30, 2021 | 177.48% |
| Mar 31, 2021 | -42.28% |
| Dec 31, 2020 | -135.00% |
| Sep 30, 2020 | -2.46% |
| Jun 30, 2020 | -54.54% |
| Mar 31, 2020 | 3.53% |
| Dec 31, 2019 | 14.61% |
| Sep 30, 2019 | -126.72% |
| Jun 30, 2019 | 35.79% |
| Mar 31, 2019 | 22.94% |
| Dec 31, 2018 | -121.42% |
| Sep 30, 2018 | 225.41% |
| Jun 30, 2018 | 8.06% |
| Mar 31, 2018 | -10.20% |
| Dec 31, 2017 | 333.27% |
| Sep 30, 2017 | -200.72% |
| Jun 30, 2017 | 28.72% |
| Mar 31, 2017 | 7.89% |
| Dec 31, 2016 | -39.63% |
| Sep 30, 2016 | 64.23% |
| Jun 30, 2016 | -169.74% |
| Mar 31, 2016 | -51.92% |
| Mar 31, 2015 | 27.16% |
| Mar 31, 2014 | 15.89% |
| Dec 31, 2013 | 7.77% |
| Sep 30, 2013 | 2.91% |
| Jun 30, 2013 | -168.35% |
| Mar 31, 2013 | -44.24% |
| Dec 31, 2012 | 121.46% |
| Sep 30, 2012 | 3.65% |
| Jun 30, 2012 | 306.69% |
| Mar 31, 2012 | -7.57% |
| Dec 31, 2011 | 19.34% |
| Sep 30, 2011 | 17.16% |